Characterization of anti-NF-κB RNA aptamer-binding specificity in vitro and in the yeast three-hybrid system

Nucleic Acids Research

Volumn 37, Issue 18, 2009, Pages 6214-6224

  Wurster, Susan E ^a   Bida, John Paul ^a   Her, Yeng F ^a   Maher III, L James ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS LINKING; ENZYME SPECIFICITY; GEL MOBILITY SHIFT ASSAY; GENE CASSETTE; GENETIC ANALYSIS; HYBRID; IN VITRO STUDY; IN VIVO STUDY; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN TERTIARY STRUCTURE; RNA BINDING; TITRIMETRY; YEAST;

APTAMERS, NUCLEOTIDE; MUTAGENESIS; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; NUCLEIC ACID CONFORMATION; PROTEIN MULTIMERIZATION; SELEX APTAMER TECHNIQUE; TRANSCRIPTION FACTOR RELA; TWO-HYBRID SYSTEM TECHNIQUES; YEASTS;

EID: 70350700732     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkp670     Document Type: Article

References (41)

1. Hayden,M.S. and Ghosh,S. (2004) Signaling to NF-kappaB. Genes Dev. 18, 2195-2224.
2. Luo,J.L., Kamata,H. and Karin,M. (2005) IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J. Clin. Invest., 115, 2625-2632.
3. Van Waes,C. (2007) Nuclear factor-kappaB in development, prevention, and therapy of cancer. Clin. Cancer Res., 13, 1076-1082.
4. Chen,F.E. and Ghosh,G. (1999) Regulation of DNA binding by Rel/NF-kappaB transcription factors: Structural views. Oncogene, 18, 6845-6852.
5. Fujita,T., Nolan,G.P., Ghosh,S. and Baltimore,D. (1992) Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev., 6, 775-787.
6. Verma,I.M., Stevenson,J.K., Schwarz,E.M., Van Antwerp,D. and Miyamoto,S. (1995) Rel/NF-kappaB/I kappaB family: Intimate tales of association and dissociation. Genes Dev., 9, 2723-2735.
7. Dutta,J., Fan,Y., Gupta,N., Fan,G. and Gelinas,C. (2006) Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene, 25, 6800-6816.
8. Karin,M. and Lin,A. (2002) NF-kappaB at the crossroads of life and death. Nat. Immunol., 3, 221-227.
9. Abdel-Latif,M.M., O'Riordan,J., Windle,H.J., Carton,E., Ravi,N., Kelleher,D. and Reynolds,J.V. (2004) NF-kappaB activation in esophageal adenocarcinoma: Relationship to Barrett's metaplasia, survival, and response to neoadjuvant chemoradiotherapy. Ann. Surg., 239, 491-500.
10. Bargou,R.C., Emmerich,F., Krappmann,D., Bommert,K., Mapara,M.Y., Arnold,W., Royer,H.D., Grinstein,E., Greiner,A., Scheidereit,C. et al. (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J. Clin. Invest., 100, 2961-2969.
11. Kojima,M., Morisaki,T., Sasaki,N., Nakano,K., Mibu,R., Tanaka,M. and Katano,M. (2004) Increased nuclear factor-kB activation in human colorectal carcinoma and its correlation with tumor progression. Anticancer Res., 24, 675-681.
12. Mukhopadhyay,T., Roth,J.A. and Maxwell,S.A. (1995) Altered expression of the p50 subunit of the NF-kappaB transcription factor complex in non-small cell lung carcinoma. Oncogene, 11, 999-1003.
13. Nair,A., Venkatraman,M., Maliekal,T.T., Nair,B. and Karunagaran,D. (2003) NF-kappaB is constitutively activated in high-grade squamous intraepithelial lesions and squamous cell carcinomas of the human uterine cervix. Oncogene, 22, 50-58.
14. Ondrey,F.G., Dong,G., Sunwoo,J., Chen,Z., Wolf,J.S., Crowl-Bancroft,C.V., Mukaida,N. and Van Waes,C. (1999) Constitutive activation of transcription factors NF-(kappa)B, AP-1, and NF-IL6 in human head and neck squamous cell carcinoma cell lines that express pro-inflammatory and pro-angiogenic cytokines. Mol. Carcin., 26 119-129.
15. Sovak,M.A., Bellas,R.E., Kim,D.W., Zanieski,G.J., Rogers,A.E., Traish,A.M. and Sonenshein,G.E. (1997) Aberrant nuclear factor-kappaB/ Rel expression and the pathogenesis of breast cancer. J. Clin. Invest., 100, 2952-2960.
16. Suh,J., Payvandi,F., Edelstein,L.C., Amenta,P.S., Zong,W.X., Gelinas,C. and Rabson,A.B. (2002) Mechanisms of constitutive NF-kappaB activation in human prostate cancer cells. Prostate, 52, 183-200.
17. Wang,W., Abbruzzese,J.L., Evans,D.B., Larry,L., Cleary,K.R. and Chiao,P.J. (1999) The nuclear factor-kappaB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res., 5, 119-127.
18. Gasparian,A.V., Yao,Y.J., Kowalczyk,D., Lyakh,L.A., Karseladze,A., Slaga,T.J. and Budunova,I.V. (2002) The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells. J. Cell Sci., 115, 141-151.
19. Madrid,L.V., Mayo,M.W., Reuther,J.Y. and Baldwin,A.S. Jr. (2001) Akt stimulates the transactivation potential of the RelA/p65 Subunit of NF-kappaB through utilization of the IkappaB kinase and activation of the mitogen-activated protein kinase p38. J. Biol. Chem., 276 18934-18940.
20. Madrid,L.V., Wang,C.Y., Guttridge,D.C., Schottelius,A.J., Baldwin,A.S. Jr. and Mayo,M.W. (2000) Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol. Cell Biol., 20, 1626-1638.
21. Nikolopoulos,S.N., Blaikie,P., Yoshioka,T., Guo,W. and Giancotti,F.G. (2004) Integrin beta4 signaling promotes tumor angiogenesis. Cancer Cell, 6, 471-483.
22. Romieu-Mourez,R., Landesman-Bollag,E., Seldin,D.C., Traish,A.M., Mercurio,F. and Sonenshein,G.E. (2001) Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res., 61, 3810-3818.
23. Tamatani,T., Azuma,M., Aota,K., Yamashita,T., Bando,T. and Sato,M. (2001) Enhanced IkappaB kinase activity is responsible for the augmented activity of NF-kappaB in human head and neck carcinoma cells. Cancer Lett., 171, 165-172.
24. Lebruska,L.L. and Maher,L.J. 3rd. (1999) Selection and characterization of an RNA decoy for transcription factor NF-kappaB. Biochemistry, 38, 3168-3174.
25. Wurster,S.E. and Maher,L.J. 3rd. (2008) Selection and characterization of anti-NF-kappaB p65 RNA aptamers. RNA, 14, 1037-1047.
26. Cassiday,L.A. and Maher,L.J. 3rd. (2001) In vivo recognition of an RNA aptamer by its transcription factor target. Biochemistry, 40 2433-2438.
27. Cassiday,L.A. and Maher,L.J. 3rd. (2003) Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappaB. Proc. Natl Acad. Sci. USA, 100, 3930-3935.
28. Konig,J., Julius,C., Baumann,S., Homann,M., Goringer,H.U. and Feldbrugge,M. (2007) Combining SELEX and the yeast three-hybrid system for in vivo selection and classification of RNA aptamers. RNA, 13, 614-622.
29. Zhang,B., Kraemer,B., SenGupta,D., Fields,S. and Wickens,M. (1999) Yeast three-hybrid system to detect and analyze interactions between RNA and protein. Methods Enzymol., 306, 93-113.
30. Cassiday,L.A., Lebruska,L.L., Benson,L.M., Naylor,S., Owen,W.G. and Maher,L.J. 3rd. (2002) Binding stoichiometry of an RNA aptamer and its transcription factor target. Anal. Biochem., 306, 290-297.
31. SenGupta,D.J., Zhang,B., Kraemer,B., Pochart,P., Fields,S. and Wickens,M. (1996) A three-hybrid system to detect RNA-protein interactions in vivo. Proc. Natl Acad. Sci. USA, 93, 8496-8501.
32. SenGupta,D.J., Wickens,M. and Fields,S. (1999) Identification of RNAs that bind to a specific protein using the yeast three-hybrid system. RNA, 5, 596-601.
33. Caponigro,G., Muhlrad,D. and Parker,R. (1993) A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae a stimulatory role for rare codons. Mol. Cell Biol., 13, 5141-5148.
34. Sengchanthalangsy,L.L., Datta,S., Huang,D.B., Anderson,E., Braswell,E.H. and Ghosh,G. (1999) Characterization of the dimer interface of transcription factor NFkappaB p50 homodimer. J. Mol. Biol., 289 1029-1040.
35. 2 complexed to a high-affinity RNA aptamer. Proc. Natl Acad. Sci. USA, 100, 9268-9273.
36. Miyakawa,S., Nomura,Y., Sakamoto,T., Yamaguchi,Y., Kato,K., Yamazaki,S. and Nakamura,Y. (2008) Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G. RNA, 14, 1154-1163.
37. King,D.J., Bassett,S.E., Li,X., Fennewald,S.A., Herzog,N.K., Luxon,B.A., Shope,R. and Gorenstein,D.G. (2002) Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50. Biochemistry, 41, 9696-9706.
38. Zhao,X., Shi,H., Sevilimedu,A., Liachko,N., Nelson,H.C. and Lis,J.T. (2006) An RNA aptamer that interferes with the DNA binding of the HSF transcription activator. Nucleic Acids Res., 34, 3755-3761.
39. Choi,Y.S., Hur,J., Lee,H.K. and Jeong,S. (2009) The RNA aptamer disrupts protein-protein interaction between beta-catenin and nuclear factor-kappaB p50 and regulates the expression of C-reactive protein. FEBS Lett., 583, 1415-1421.
40. Ghosh,G., Huang,D.B. and Huxford,T. (2004) Molecular mimicry of the NF-kappaB DNA target site by a selected RNA aptamer. Curr. Opin. Struct. Biol., 14, 21-27.
41. Mi,J., Zhang,X., Liu,Y., Reddy,S.K., Rabbani,Z.N., Sullenger,B.A. and Clary,B.M. (2007) NF-kappaB inhibition by an adenovirus expressed aptamer sensitizes TNFalpha-induced apoptosis. Biochem. Biophys. Res. Commun., 359, 475-480.